GT reports mixed third-quarter results and expects full-year 2024 capital expenditures to be $1.20 billion, down from the previous estimate of $1.25...

CMI reports better-than-expected third-quarter results and anticipates 2024 EBITDA to be 15.5% compared with the prior guided range of 15-15.5%.

OSK reports better-than-expected third-quarter results and expects 2024 sales to be around $10.6 billion, down from the previous expectation of $10.7...

PCRX reports mixed third-quarter 2024 results, wherein earnings beat estimates but revenues miss. Exparel sales witness year-over-year growth.

DENTSPLY SIRONA's third-quarter results showcase strong top-line growth in the Essential Dental Solutions segment. However, the lowered outlook for...

FOLD's third-quarter 2024 earnings and sales beat the Zacks Consensus Estimate. The company raises its financial guidance for 2024.

Trimble's third-quarter 2024 results benefit from strong subscription and services revenues, backed by robust guidance for continued growth.

GPI's third-quarter earnings miss the Zacks Consensus Estimate, whereas, revenues beat the same.

MRNA reports better-than-expected third-quarter earnings. It reiterates the guidance of product sales to between $3 billion and $3.5 billion for 2024.

ABG reports lower-than-expected third-quarter results, wherein revenues rise year over year.